Skip to Main Content

Author Details

Nevan J Krogan (CM4AI)
University of California San Francisco
0000-0003-4902-337X
1998
522
125
Data acquisition
PMIDPaper TitleJournal TitlePublished Year
37090610A proximity proteomics pipeline with improved reproducibility and throughput.bioRxiv2024
35298864Integrative structure determination of histones H3 and H4 using genetic interactions.FEBS J2023
37865089De novo protein identification in mammalian sperm using in situ cryoelectron tomography and AlphaFold2 docking.Cell2023
37758692Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.Nat Commun2023
37863045The multi-lineage transcription factor ISL1 controls cardiomyocyte cell fate through interaction with NKX2.5.Stem Cell Reports2023
37858338High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma.Cell Rep Med2023
37857833A Legionella toxin exhibits tRNA mimicry and glycosyl transferase activity to target the translation machinery and trigger a ribotoxic stress response.Nat Cell Biol2023
37620325Next-generation proteomics for quantitative Jumbophage-bacteria interaction mapping.Nat Commun2023
38060380Molecular determinants of the crosstalk between endosomal microautophagy and chaperone-mediated autophagy.Cell Rep2023
37651466A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo.PLoS Pathog2023
37738983Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.Cell Host Microbe2023
37738970SARS-CoV-2 variants evolve convergent strategies to remodel the host response.Cell2023
37938000Hepatitis C virus infects and perturbs liver stem cells.mBio2023
37577546Cross-family small GTPase ubiquitination by the intracellular pathogen <i>Legionella pneumophila</i>.bioRxiv2023
37873080Lysosomal proteomics reveals mechanisms of neuronal apoE4associated lysosomal dysfunction.bioRxiv2023
37220749A multi-scale map of protein assemblies in the DNA damage response.Cell Syst2023
36993679Merlin<sup>S13</sup> phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features.Res Sq2023
37291385Defining blood-induced microglia functions in neurodegeneration through multiomic profiling.Nat Immunol2023
37321167Lessons learned for pandemic preparedness: A collaborative network is imperative.Cell Host Microbe2023
37252973Dengue virus NS5 degrades ERC1 during infection to antagonize NF-kB activation.Proc Natl Acad Sci U S A2023
37019383Quantitative Proteomic Analysis Reveals apoE4-Dependent Phosphorylation of the Actin-Regulating Protein VASP.Mol Cell Proteomics2023
37213254Current proteomics methods applicable to dissecting the DNA damage response.NAR Cancer2023
37336883Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3.Nat Commun2023
37204043Network modeling suggests HIV infection phenocopies PI3K-AKT pathway mutations to enhance HPV-associated cervical cancer.Mol Omics2023
37131711A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis <i>in vivo</i>.bioRxiv2023
36782050Structure and dynamics of the essential endogenous mycobacterial polyketide synthase Pks13.Nat Struct Mol Biol2023
36747776Structure and dynamics of the essential endogenous mycobacterial polyketide synthase Pks13.bioRxiv2023
36692000Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms.Elife2023
36711836Next-generation interaction proteomics for quantitative Jumbophage-bacteria interaction mapping.bioRxiv2023
36603024Nuclear accumulation of host transcripts during Zika Virus Infection.PLoS Pathog2023
35018374SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.bioRxiv2022
35839775Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2.Cell Rep2022
35439318A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor.Mol Cancer Ther2022
35730550Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries.Glob Health Action2022
35534562Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.Nat Genet2022
35365639A functional map of HIV-host interactions in primary human T cells.Nat Commun2022
35695185DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression.Development2022
36549272How can systems approaches help us understand and treat infectious disease?Cell Syst2022
36075902Structure-function analysis of enterovirus protease 2A in complex with its essential host factor SETD3.Nat Commun2022
36073812CCL2: a Chemokine Potentially Promoting Early Seeding of the Latent HIV Reservoir.mBio2022
35938400Transcription Factor GATA4 Regulates Cell Type-Specific Splicing Through Direct Interaction With RNA in Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitors.Circulation2022
36273492Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.Cancer Res2022
36241425Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.Life Sci Alliance2022
36066422A balancing act: interactions within NuA4/TIP60 regulate picNuA4 function in Saccharomyces cerevisiae and humans.Genetics2022
36095012SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.PLoS Pathog2022
36087581Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.Neuron2022
36052496Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2022
36052495Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2022
36116133Reduced endosomal microautophagy activity in aging associates with enhanced exocyst-mediated protein secretion.Aging Cell2022
35291294Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.bioRxiv2022
  • 1 - 50 of 387

Recommended Authors

Nidhi Sahni
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 17
Anna Y Lee
Ontario Institute for Cancer Research
Career Start Year 2007
Number of shared co-authors 9
Song Yi
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 2006
Number of shared co-authors 18
Kelly R Molloy
The Rockefeller University
Career Start Year 2006
Number of shared co-authors 3
Caroline C Friedel
Institute of Informatics, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2005
Number of shared co-authors 6
Chad L Myers
University of Minnesota - Twin Cities
Career Start Year 2004
Number of shared co-authors 54
Christopher C Ebmeier
University of Colorado
Career Start Year 2004
Number of shared co-authors 9
Christine Vogel
Center for Genomics and Systems Biology, New York University
Career Start Year 2003
Number of shared co-authors 9
Ileana M Cristea
Princeton University
Career Start Year 2003
Number of shared co-authors 26
Roland Krause
University of Luxembourg
Career Start Year 2002
Number of shared co-authors 5
Lorrie Boucher
The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 2001
Number of shared co-authors 8
Andrew P VanDemark
University of Pittsburgh
Career Start Year 2000
Number of shared co-authors 1
Jeroen A A Demmers
Erasmus Medical Center
Career Start Year 2000
Number of shared co-authors 10
Chandra L Theesfeld
Lewis-Sigler Institute for Integrative Genomics, Princeton University
Career Start Year 1996
Number of shared co-authors 11
Christopher T Workman
Technical University of Denmark
Career Start Year 1995
Number of shared co-authors 18
Brian Raught
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1994
Number of shared co-authors 43
Anne-Claude Gingras
Lunenfeld-Tanenbaum Research Institute
Career Start Year 1994
Number of shared co-authors 89
Matthias Gstaiger
Institute of Molecular Systems Biology, ETH Zurich
Career Start Year 1994
Number of shared co-authors 20
Ioannis Xenarios
University of Lausanne
Career Start Year 1994
Number of shared co-authors 28
Peter Uetz
Center for the Study of Biological Complexity, Virginia Commonwealth University
Career Start Year 1994
Number of shared co-authors 34
Edward M Marcotte
University of Texas
Career Start Year 1993
Number of shared co-authors 36
Jason E McDermott
Pacific Northwest National Laboratory
Career Start Year 1993
Number of shared co-authors 8
Marc R Wilkins
University of New South Wales
Career Start Year 1992
Number of shared co-authors 15
Zhiping Weng
University of Massachusetts Medical School
Career Start Year 1992
Number of shared co-authors 35
Andreas Beyer
University of Cologne
Career Start Year 1991
Number of shared co-authors 21
Jeffrey A Ranish
Institute for Systems Biology
Career Start Year 1991
Number of shared co-authors 14
Marc Gillespie
Ontario Institute for Cancer Research
Career Start Year 1990
Number of shared co-authors 8
John D Aitchison
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year 1988
Number of shared co-authors 14
Mike Tyers
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Career Start Year 1986
Number of shared co-authors 53
Gianni Cesareni
University of Rome 'Tor Vergata'
Career Start Year 1976
Number of shared co-authors 25

Collaborators

Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 65
Jack F Greenblatt
College Street, University of Toronto
Co-authored papers 53
Danielle L Swaney
J. David Gladstone Institutes
Co-authored papers 53
Michael Shales
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers 36
Assen Roguev
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers 33
Mehdi Bouhaddou
J. David Gladstone Institutes
Co-authored papers 30
Gerard Cagney
Conway Institute of Biomedical and Biomolecular Sciences, University College Dublin
Co-authored papers 29
Andrew Emili
Boston University School of Medicine, Boston University
Co-authored papers 27
Hannes Braberg
University of California San Francisco
Co-authored papers 25
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 25
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers 25
Gwendolyn M Jang
Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes
Co-authored papers 24
Melanie Ott
Gladstone Institute of Virology
Co-authored papers 23
Sean R Collins
University of California davis
Co-authored papers 22
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Co-authored papers 22
Jiewei Xu
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 22
Jonathan S Weissman
Whitehead Institute for Biomedical Research
Co-authored papers 21
Kevan M Shokat
University of California San Francisco
Co-authored papers 20
Pedro Beltrao
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 20
Ruth H??ttenhain
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 19
Billy W Newton
University of California San Francisco
Co-authored papers 19
Robyn M Kaake
J. David Gladstone Institutes
Co-authored papers 17
David Jimenez-Morales
J. David Gladstone Institutes
Co-authored papers 17
Timothy R Hughes
University of Toronto
Co-authored papers 16
Colm J Ryan
University College Dublin
Co-authored papers 16
Margaret Soucheray
J. David Gladstone Institutes
Co-authored papers 16
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 15
Michael-Christopher Keogh
EpiCypher Inc.
Co-authored papers 15
John Von Dollen
University of California San Francisco
Co-authored papers 15
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 15
Release 1.2